The European Commission published, on Tuesday 28 April, a new version of its guidance on the management of clinical trials during the Covid-19 pandemic, which provides for special time-limited measures.
This document aims to provide a harmonised set of recommendations to ensure the safety of trial participants throughout the EU while preserving the quality of the trial data. The guidelines also ensure that clinical trials for other treatments, in particular those for rare diseases and...